Lung protective ventilation based on donor size is associated with a lower risk of severe primary graft dysfunction after lung transplantation.
Lung protective ventilation based on donor size is associated with a lower risk of severe primary graft dysfunction after lung transplantation.
复制标题
DOI:
10.1016/j.healun.2021.06.016
复制
发表时间:
2021-10
期刊:
影响因子:
--
通讯作者:
Hachem RR
中科院分区:
文献类型:
--
作者:
Tague LK;Bedair B;Witt C;Byers DE;Vazquez-Guillamet R;Kulkarni H;Alexander-Brett J;Nava R;Puri V;Kreisel D;Trulock EP;Gelman A;Hachem RR
Mechanical ventilation immediately after lung transplantation may impact the development of primary graft dysfunction (PGD), particularly in cases of donor-recipient size mismatch as ventilation is typically based on recipient rather than donor size. We conducted a retrospective cohort study of adult bilateral lung transplant recipients at our center between January 2010 and January 2017. We defined donor-based lung protective ventilation (dLPV) as 6 to 8 ml/kg of donor ideal body weight and plateau pressure <30 cm H2O. We calculated the donor-recipient predicted total lung capacity (pTLC) ratio and used logistic regression to examine relationships between pTLC ratio, dLPV and PGD grade 3 at 48 to 72 hours. We used Cox proportional hazards modelling to examine the relationship between pTLC ratio, dLPV and 1-year survival. The cohort included 373 recipients; 24 (6.4%) developed PGD grade 3 at 48 to 72 hours, and 213 (57.3%) received dLPV. Mean pTLC ratio was 1.04 ± 0.18. dLPV was associated with significantly lower risks of PGD grade 3 (OR = 0.44; 95% CI: 0.29–0.68, p < 0.001) and 1-year mortality (HR = 0.49; 95% CI: 0.29–0.8, p = 0.018). There was a significant association between pTLC ratio and the risk of PGD grade 3, but this was attenuated by the use of dLPV. dLPV is associated with decreased risk of PGD grade 3 at 48 to 72 hours and decreased 1-year mortality. Additionally, dLPV attenuates the association between pTLC and both PGD grade 3 and 1-year mortality. Donor-based ventilation strategies may help to mitigate the risk of PGD and other adverse outcomes associated with size mismatch after lung transplantation.
登录
查看更多内容
DOI:
10.1186/cc8230
发表时间:
2010
期刊:
Critical care (London, England)
影响因子:
--
作者:
Determann RM;Royakkers A;Wolthuis EK;Vlaar AP;Choi G;Paulus F;Hofstra JJ;de Graaff MJ;Korevaar JC;Schultz MJ
通讯作者:
Schultz MJ
影响因子:
5.7
作者:
Lee, James C.;Christie, Jason D.
通讯作者:
Christie, Jason D.
影响因子:
8.9
作者:
Chambers, Daniel C.;Cherikh, Wida S.;Stehlik, Josef
通讯作者:
Stehlik, Josef
影响因子:
8.9
作者:
Christie, Jason D.;Bellamy, Scarlett;Kawut, Steven M.
通讯作者:
Kawut, Steven M.
DOI:
10.1164/rccm.200409-1243oc
发表时间:
2005-06-01
影响因子:
24.7
作者:
Christie, JD;Kotloff, RM;Kimmel, SE
通讯作者:
Kimmel, SE